Contact

All Stories

  1. QRISK3 improves detection of cardiovascular disease risk in patients with systemic lupus erythematosus

    Article • Lupus Science & Medicine, August 2018, BMJ

    Dr Alex Langford-Smith

  2. Macrophage enzyme and reduced inflammation drive brain correction of mucopolysaccharidosis IIIB by stem cell gene therapy

    Article • Brain, November 2017, Oxford University Press (OUP)

    Dr Alex Langford-Smith

  3. microparticles and endothelial dysfunction

    Article • The FASEB Journal, July 2017, Federation of American Societies For Experimental Biology (FASEB)

    Dr Ayman M Mahmoud, Juan Duarte, Dr Alex Langford-Smith

  4. Age and Smoking Related Changes in Metal Ion Levels in Human Lens: Implications for Cataract Formation

    Article • PLoS ONE, January 2016, PLOS

    Dr Alex Langford-Smith

  5. Corrigendum

    Article • Brain, June 2015, Oxford University Press (OUP)

    Dr Alex Langford-Smith

  6. Complementing the Sugar Code: Role of GAGs and Sialic Acid in Complement Regulation

    Article • Frontiers in Immunology, February 2015, Frontiers

    Dr Alex Langford-Smith

  7. Neuroinflammation, mitochondrial defects and neurodegeneration in mucopolysaccharidosis III type C mouse model

    Article • Brain, January 2015, Oxford University Press (OUP)

    Dr Alex Langford-Smith

  8. The Role of Complement in Age-Related Macular Degeneration: Heparan Sulphate, a ZIP Code for Complement Factor H?

    Article • Journal of Innate Immunity, December 2013, Karger Publishers

    Dr Alex Langford-Smith

  9. Signal One and Two Blockade Are Both Critical for Non-Myeloablative Murine HSCT across a Major Histocompatibility Complex Barrier

    Article • PLoS ONE, October 2013, PLOS

    Dr Alex Langford-Smith

  10. Myeloid/Microglial Driven Autologous Hematopoietic Stem Cell Gene Therapy Corrects a Neuronopathic Lysosomal Disease

    Article • Molecular Therapy, October 2013, Elsevier

    Dr Alex Langford-Smith

  11. Neuropathological changes are more pronounced in mouse models of Mucopolysaccharidosis (MPS) type IIIA and IIIB over MPS I

    Article • Molecular Genetics and Metabolism, February 2013, Elsevier

    Dr Alex Langford-Smith

  12. Hematopoietic Stem Cell and Gene Therapy Corrects Primary Neuropathology and Behavior in Mucopolysaccharidosis IIIA Mice

    Article • Molecular Therapy, August 2012, Elsevier

    Dr Alex Langford-Smith

  13. Neuropathology in Mouse Models of Mucopolysaccharidosis Type I, IIIA and IIIB

    Article • PLoS ONE, April 2012, PLOS

    Dr Alex Langford-Smith

  14. Female Mucopolysaccharidosis IIIA Mice Exhibit Hyperactivity and a Reduced Sense of Danger in the Open Field Test

    Article • PLoS ONE, October 2011, PLOS

    Dr Alex Langford-Smith

  15. Hyperactive behaviour in the mouse model of mucopolysaccharidosis IIIB in the open field and home cage environments

    Article • Genes Brain & Behavior, June 2011, Wiley

    Dr Alex Langford-Smith

  16. Genistein Improves Neuropathology and Corrects Behaviour in a Mouse Model of Neurodegenerative Metabolic Disease

    Article • PLoS ONE, December 2010, PLOS

    Dr Alex Langford-Smith